CMS modified NCD 345 governing transtelephonic monitoring of cardiac pacemakers, effective January 9, 2026. Here's what billing teams need to do.
The Centers for Medicare & Medicaid Services updated NCD 345, the National Coverage Determination governing Medicare coverage of transtelephonic pacemaker monitoring services. This policy covers monitoring furnished by commercial suppliers, hospital outpatient departments, and physicians' offices. The update reinforces strict frequency guidelines that your Medicare Administrative Contractor will use to screen claims before payment — and if your documentation doesn't line up, you're looking at claim denial.
Quick-Reference Table
| Field | Detail |
|---|---|
| Payer | CMS (Centers for Medicare & Medicaid Services) |
| Policy | Transtelephonic Monitoring of Cardiac Pacemakers |
| Policy Code | NCD 345 |
| Change Type | Modified |
| Effective Date | January 9, 2026 |
| Impact Level | Medium |
| Specialties Affected | Cardiology, Electrophysiology, Hospital Outpatient Departments, Physicians' Offices, Commercial Monitoring Suppliers |
| Key Action | Audit your monitoring documentation to confirm each claim includes the three required ECG strip elements and falls within MAC-approved frequency thresholds |
CMS Transtelephonic Pacemaker Monitoring Coverage Criteria and Medical Necessity Requirements 2026
The CMS transtelephonic pacemaker monitoring coverage policy is built on a straightforward clinical premise: telephone monitoring detects early signs of pacemaker failure before a patient ends up in the ER with a dead device. That's the medical necessity argument, and CMS accepts it — but only when you document the right elements and bill at the right frequency.
To meet medical necessity under NCD 345, every monitoring session must include three specific elements. Miss one, and you've billed a service that doesn't meet the coverage policy definition.
The three required elements are:
| # | Covered Indication |
|---|---|
| 1 | A minimum 30-second readable strip of the pacemaker in the free-running mode |
| 2 | A minimum 30-second readable strip of the pacemaker in the magnetic mode (unless contraindicated) |
| 3 | A minimum 30 seconds of readable ECG strip |
All three must be documented. "Readable" is doing real work in this policy — an artifact-heavy or incomplete strip isn't going to hold up on review. Train your clinical staff on what "readable" means in the context of a MAC audit.
The magnetic mode strip has one out: it can be skipped when contraindicated. But if you skip it, document why. MACs will look for that justification.
Prior Authorization and Medical Necessity for Frequency
There's no specific prior authorization requirement named in NCD 345. But the frequency guidelines function as a practical prior authorization screen. Your MAC uses these thresholds to approve or flag claims before payment — exceeding the threshold without written physician justification triggers additional claims development, which is the MAC's version of asking "prove it."
If a patient's condition requires more frequent monitoring than the guidelines allow, you need written justification from the treating physician and/or the monitoring service. Get that documentation before you bill — not after you receive a request for records.
CMS Transtelephonic Pacemaker Monitoring Frequency Guidelines and Coverage Rules 2026
This is where the policy gets specific, and where most billing errors will occur. The frequency guidelines divide pacemakers into two main categories. Understanding which category applies to each patient is the most important thing your billing team can do right now.
Guideline I applies to the majority of pacemakers currently in use. If you don't know for certain that a pacemaker system qualifies under Guideline II, bill under Guideline I.
Guideline II applies only to pacemaker systems — both the pacemaker and leads — that meet the Inter-Society Commission for Heart Disease Resources (ICHD) standards for longevity and end-of-life decay. Those standards are specific:
- 90% cumulative survival at five years following implant
- End-of-life decay of less than a 50% drop in output voltage, AND less than 20% deviation of magnet rate, OR a drop of five beats per minute or less over a period of three months or more
If your monitoring organization isn't sure whether a specific device meets ICHD standards, consult the North American Society of Pacing and Electrophysiology, which publishes product reliability data. Your MAC's medical adviser is also a resource. Don't guess.
Single-Chamber vs. Dual-Chamber Pacemakers
Each guideline category is further broken down by device type: single-chamber and dual-chamber pacemakers. Dual-chamber devices carry additional clinical complexity — the monitoring may detect failure of synchronization between the atria and ventricles, and the need for reprogramming. That complexity is reflected in the frequency guidelines, which differ between device types.
Your billing team needs to know which device type each patient has. That information should come from the ordering physician's documentation and the device record. If your intake process doesn't capture single-chamber vs. dual-chamber status, fix that process now — before the January 9, 2026 effective date has claims rolling through your system.
Maximum Frequency, Not Minimum
Here's a nuance that trips up billing teams: these guidelines set a maximum frequency for automatic payment, not a minimum standard of care. Billing below the threshold is fine. Billing above it without written justification is what generates claims development and potential denial.
More frequent monitoring can be covered when your MAC determines medical necessity — for example, when a patient's condition is deteriorating, or when a pacemaker is showing unexpected defects or premature failure. But "can be covered" means "will be scrutinized." The reimbursement is there, but the documentation burden is higher.
CMS Transtelephonic Pacemaker Monitoring Exclusions and Non-Covered Indications
The transmitting device furnished to the patient is not covered as durable medical equipment (DME). This is explicit in NCD 345, and it matters for how you structure your billing.
The transmitter is one component of the diagnostic system. CMS treats it as part of the monitoring service infrastructure, not as a separately billable DME item. Suppliers and hospital outpatient departments should factor transmitter costs into their monitoring service charges — not bill the device separately under a DME benefit category.
If your organization has been billing the transmitter as DME, stop. That's a claim denial waiting to happen, and it's a repayment risk on historical claims. Talk to your compliance officer about whether a look-back is warranted.
Coverage Indications at a Glance
| Indication | Status | Relevant Codes | Notes |
|---|---|---|---|
| Transtelephonic monitoring with all three required elements (free-running strip, magnetic strip, ECG strip) — single-chamber pacemaker, Guideline I | Covered | Policy does not list specific codes | Must fall within MAC frequency thresholds; written physician justification required for higher frequency |
| Transtelephonic monitoring — dual-chamber pacemaker, Guideline I | Covered | Policy does not list specific codes | Dual-chamber frequency limits apply; document atrial-ventricular synchronization assessment |
| Transtelephonic monitoring — single-chamber pacemaker, Guideline II (ICHD-qualifying device) | Covered | Policy does not list specific codes | Device must meet ICHD longevity and end-of-life decay standards; confirm with NASPE or MAC adviser |
| Transtelephonic monitoring — dual-chamber pacemaker, Guideline II (ICHD-qualifying device) | Covered | Policy does not list specific codes | Same ICHD qualification requirement; document device eligibility |
| Monitoring exceeding frequency thresholds with documented medical necessity | Covered | Policy does not list specific codes | Requires written justification from treating physician and/or monitoring service before claim submission |
| Transmitting device furnished to patient | Not Covered as DME | Policy does not list specific codes | Include transmitter cost in monitoring service charge; do not bill separately as DME |
| Monitoring without all three required readable strip elements | Not Covered | Policy does not list specific codes | Missing or unreadable strips fail the definition of a covered service |
CMS Transtelephonic Pacemaker Monitoring Billing Guidelines and Action Items 2026
The policy is clear. The documentation requirements are specific. Here's what your team needs to do before and after January 9, 2026.
| # | Action Item |
|---|---|
| 1 | Audit your documentation templates now. Confirm every monitoring record captures all three required elements: the free-running strip, the magnetic strip (or documented contraindication), and the ECG strip. If your template doesn't have fields for all three, update it before the effective date. |
| 2 | Identify every patient's pacemaker type in your system. Single-chamber and dual-chamber pacemakers have different frequency thresholds. Dual-chamber patients also require documentation of atrial-ventricular synchronization monitoring. Your intake workflow should capture device type at enrollment and verify it at each monitoring session. |
| 3 | Determine which guideline applies to each device — I or II. For devices that might qualify under Guideline II, verify ICHD compliance using NASPE product reliability data or by consulting your MAC's medical adviser. Document your determination in the patient record. Don't apply Guideline II frequencies to a device you haven't confirmed qualifies. |
| 4 | Pull your historical claims for transmitter device billing. If your organization has billed the patient transmitter as DME, identify those claims and loop in your compliance officer. NCD 345 explicitly excludes the transmitter from DME coverage. This is both a prospective billing guidelines issue and a potential retrospective repayment exposure. |
| 5 | Create a process for documenting above-threshold frequency. When a patient's clinical condition requires monitoring more frequently than the MAC thresholds allow, get written justification from the treating physician before billing — not as an afterthought when the MAC requests records. Build this into your workflow as a required pre-billing step. |
| 6 | Brief your MACs on your monitoring mix. Transtelephonic pacemaker billing is a MAC-administered coverage policy. Different MACs may apply the frequency guidelines differently based on local medical practice knowledge. Know which MAC covers your jurisdiction and what their current screening thresholds look like. If you're not sure, call them. |
| 7 | Train your clinical documentation staff on "readable strip" standards. The policy requires readable strips — not just strips. ECG artifact, poor signal quality, or incomplete transmission creates documentation that won't support a claim under NCD 345. Set an internal quality standard before a MAC audit sets one for you. |
| Previous Version | Current Version |
|---|---|
| Coverage is considered experimental and investigational for all indications | Coverage is considered medically necessary when specific criteria are met |
| Prior authorization is not required | Prior authorization is required for initial treatment |
| Documentation must include clinical history | Documentation must include clinical history |
| Re-review every 24 months | Re-review every 12 months with updated clinical documentation |
CPT, HCPCS, and ICD-10 Codes for Transtelephonic Pacemaker Monitoring Under NCD 345
Covered and Applicable Codes
NCD 345 does not list specific CPT or HCPCS codes in the policy data available for this update. This is common for older NCDs that predate current code-level specificity in CMS policy documents.
For transtelephonic pacemaker monitoring billing, work with your MAC to confirm the current applicable procedure codes in your jurisdiction. Your MAC's local coverage determination (LCD) or billing guidance will specify the codes used to report these services. Do not assume a code applies without MAC confirmation — the wrong code on a pacemaker monitoring claim creates both a claim denial risk and a potential compliance issue.
What to Ask Your MAC
Contact your MAC and ask specifically:
- Which CPT or HCPCS codes they accept for transtelephonic pacemaker monitoring under NCD 345
- Whether they have an active LCD that supplements NCD 345 with code-level guidance
- Whether frequency thresholds vary by code (some MACs distinguish between codes for single-session monitoring vs. monthly service bundles)
If your MAC has an LCD that references NCD 345, that LCD's code list governs your billing in that jurisdiction.
Get the Full Picture
Track this policy across versions, search 1,500+ policies by CPT code, and get real-time alerts when any payer changes coverage.